BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BioElectronics Corporation' Study on Postoperative Pain Reduction Published in the Aesthetic Plastic Surgery Journal


11/3/2011 7:42:04 AM

FREDERICK, MD--(Marketwire - November 03, 2011) -

BioElectronics Corporation (PINKSHEETS: BIEL) (OTCQB: BIEL), the maker of inexpensive, disposable drug-free topical pain and healing devices, today announced the publication of an article in the peer reviewed journal Aesthetic Plastic Surgery that demonstrates the effective use of BioElectronics Corporation Pulsed Radio Frequency Energy (PRFE) therapy to reduce postoperative pain.

"Postoperative pain is still a major problem that continues to be undertreated. There are significant benefits to controlling postoperative pain, including faster surgical recovery with fewer postsurgical complications. With this published study BioElectronics clearly shows that its innovative medical devices can significantly contribute to patients experiencing a decreased amount of postoperative pain. In this particular clinical study, there was at least a 50% reduction in postoperative pain compared to the placebo group," commented Ian Rawe, PhD, BioElectronics Director of Clinical Research. "We are progressing with larger clinical studies, for example, our 200 patient C-section recovery study, and are confident that these clinical studies will produce results that support, and add to the finding presented in this published article."

"It has been clear to us for a long time that our products reduce the amount of patient pain when recovering from a soft tissue injury," commented Arnon Horev, BioElectronics VP Sales and Marketing. "We believe that peer reviewed publication of our clinical studies can only benefit BioElectronics in gaining greater recognition and acceptance of our innovative products in the medical community."

The article, titled, "Control of Postoperative Pain with a Wearable Continuously Operating Pulsed Radiofrequency Energy Device: A Preliminary Study" can be viewed at: http://www.ncbi.nlm.nih.gov/pubmed/22037572

About BioElectronics Corporation
BioElectronics is an award winning medical device developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal complaints, the Allay™ Menstrual Cycle Pain Therapy, and RecoveryRx™ for surgical procedures and wound care. The unique therapy delivery system, using patented technology, provides a cost-effective home care to reduce soft tissue pain and swelling. For more information, please see www.bielcorp.com.


Contact:
Ben Fichter
BioElectronics Corporation
(301) 874-4890

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES